BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2019
View Archived Issues
Novel mouse models of chronic sustained hypoxia and chronic intermittent hypoxia
Read More
OP-1250 shrinks ER-positive breast tumors in xenograft models
Read More
Vaccitech Oncology collaborates with Cancer Research UK on phase I/IIa study of VTP-600 vaccine
Read More
Zentalis begins phase I/II trial of DDR drug candidate ZN-c3
Read More
Genistein analogue AXP-107-11 acts as chemoenhancer in pancreatic ductal adenocarcinoma
Read More
Lack of clinical effect with AVL-3288 in phase Ib trial in schizophrenia patients
Read More
Freeline Therapeutics describes novel next-generation AAV-hFVIII vector candidate
Read More
Microbiome-based therapies may be useful against ALDs
Read More
Ryaltris receives marketing approval in Australia
Read More
'Aggrephagy' is viral immune evasion mechanism
Read More
Jiangsu Vcare Pharmatech describes new EGFR inhibitors
Read More
New cannabinoid CB1/2 receptor ligands discovered at AL&AM Pharmachem
Read More
Shionogi presents new histone deacetylase inhibitors
Read More
Merck & Co. patents HIV integrase inhibitors
Read More
New protein cereblon ligands identified at C4 Therapeutics
Read More
FDA approves Dayvigo for insomnia
Read More
Orkedia approved in Japan for hypercalcemia in parathyroid carcinoma or primary hyperparathyroidism
Read More
FDA approves Enhertu for unresectable or metastatic HER2-positive breast cancer
Read More
Quantum Genomics begins phase III study of firibastat in hypertension
Read More
New INDUCE-3 trial studies GSK-3359609 and pembrolizumab for PD-L1-positive HNSCC
Read More
FDA issues complete response letter for long-acting cabotegravir/rilpivirine regimen for HIV
Read More
InxMed gains clearance in China for phase I trial of IN-10018
Read More